Molecular subtypes and precision treatment of triple-negative breast cancer

Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype. Despite the progress made in precision treatment of cancer patients, targeted treatment is still at its early stage in TNBC, and chemotherapy remains the standard treatment. With the advances in next generation sequen...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Shen, Zuo, Wen-Jia, Shao, Zhi-Ming, Jiang, Yi-Zhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210152/
https://www.ncbi.nlm.nih.gov/pubmed/32395543
http://dx.doi.org/10.21037/atm.2020.03.194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210152/
https://www.ncbi.nlm.nih.gov/pubmed/32395543
http://dx.doi.org/10.21037/atm.2020.03.194

Ejemplares similares